(-)-Kusunokinin as a Potential Aldose Reductase Inhibitor: Equivalency Observed via AKR1B1 Dynamics Simulation
(-)-Kusunokinin performed its anticancer potency through CFS1R and AKT pathways. Its ambiguous binding target has, however, hindered the next development phase. Our study thus applied molecular docking and molecular dynamics simulation to predict the protein target from the pathways. Among various c...
Saved in:
Main Authors: | Tanotnon Tanawattanasuntorn, Tienthong Thongpanchang, Thanyada Rungrotmongkol, Chonnikan Hanpaibool, Potchanapond Graidist, Varomyalin Tipmanee |
---|---|
Other Authors: | Chulalongkorn University |
Format: | Article |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/76550 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Trans-(−)-kusunokinin: A potential anticancer lignan compound against her2 in breast cancer cell lines?
by: Thidarath Rattanaburee, et al.
Published: (2022) -
Inhibition of CSF1R and AKT by (±)-kusunokinin hinders breast cancer cell proliferation
by: Thidarath Rattanaburee, et al.
Published: (2020) -
Trans-(±)-Kusunokinin Binding to AKR1B1 Inhibits Oxidative Stress and Proteins Involved in Migration in Aggressive Breast Cancer
by: Tanawattanasuntorn T.
Published: (2023) -
Trans-(±)-kusunokinin suppresses AKR1B1: inhibition of oxidative stress and alteration of epithelial-mesenchymal transition markers on aggressive cancer
by: Tanawattanasuntorn T.
Published: (2023) -
Identification and validation of cancerous targets of kusunokinin
by: Tanotnon Tanawattanasuntorn
Published: (2023)